Prof of Medicine & Assoc Chief of Basic Research @UofUHematology @UofUInternalMed @UU_MolecularMed @UofUMandI Hematopoiesis, immunology, development
Salt Lake City, UT
Joined January 2017
- Tweets1.2K
- Following1.4K
- Followers1.8K
- Likes7.3K
Anna E. Beaudin retweeted
Announcing another round of funding applications for P&F Type B awards! Application deadline is March 16th, 2026 (5 PM MST). Learn more and apply here cceh.io/funding/.
Anna E. Beaudin retweeted
Join global leaders in hematopoiesis, bone marrow biology & stem cell research at Keystone Symposia:
📅 Feb 23–26, 2026
📍 Keystone, CO, USA
🌐 keysym.us/KSHemato26
#hematopoiesis #bonemarrow #hematopoieticstemcells
Anna E. Beaudin retweeted
Congratulations to Dr. Kevin Hicks and Dr. Aaron Petrey, CIHD P&F Pilot Award Recipients!
Anna E. Beaudin retweeted
Congrats to the University of Utah's Dr. Betty Leibold who, together with Drs. Matthias Hentze, Tracey Rouault and Lukas Kuhn, received the Marcel Simon Award for the discovery of the IRE-IPR regulatory system at the 10th Congress of the International BioIron Society in Montreal!
Anna E. Beaudin retweeted
ASH has made an unprecedented investment of more than $12 million. Including ~$9 million increase in award funding. Total awards commitment of more than $20 million over the next 12 months....providing support for an additional 600+ awardees at all career stages. @ASH_hematology
Anna E. Beaudin retweeted
Utah CIHD trainees Allison Fisher, Audrey Belot, and Brian Czaya represent at the BioIron Meeting in Montreal May 2025!
Anna E. Beaudin retweeted
We are pleased to announce that our Center for Iron and Heme Disorders (CIHD) within the Division of Hematology at the University of Utah School of Medicine will fund two to three small pilot grants in 2025. Please see details here cihd.cores.utah.edu/funding/.
Anna E. Beaudin retweeted
Our next meeting from the CIHD Virtual Seminar Series 2024-2025 on Tuesday, January 14th at 9:00 am MT! “Determinants of Maternal-Fetal Iron Partitioning - New Approaches and Unresolved Questions” presented by Kimberly O’Brien, Ph.D. @NIDDKgov
Anna E. Beaudin retweeted
🌟 Dr Bobillo presenting RWE for #lisocel in 2nd line LBCL to packed session @UUtah @huntsmancancer @WomenInLymphoma @CIBMTR #ASH2024 – at California, USA
Anna E. Beaudin retweeted
My very talented graduate student @nsarellano9 wrote a highlight in @eLife on beautiful work by first author Rebecca Warfvinge that links cellular heterogeneity in CML stem cells to TKI response. Check both out below!
elifesciences.org/articles/9…
elifesciences.org/articles/1…
Anna E. Beaudin retweeted
First author @GliceidaGalarza is one of our amazingly talented @UtahHemeOnc fellows @huntsmancancer
Awesome work Gli! 💫💫💫 @BloodCancerJnl #mmsm
1/ 🚨 Now in @BloodCancerJnl - our multicenter description of IEC-associated enterocolitis as a novel toxicity of CAR-T in myeloma #MMsm.
Typically non-bloody Gr3+ diarrhea starting ~3 mo after ide-cel or cilta-cel: 36% cases fatal in our series (n=14).
nature.com/articles/s41408-0…
Anna E. Beaudin retweeted
Online Now! A distinct metabolic and epigenetic state drives trained immunity in HSC-derived macrophages from autoimmune mice dlvr.it/TFMpXX #stemcells
Anna E. Beaudin retweeted
Congrats to Dr. Benjamin Mizukawa & Dr. Yi Zheng on their recent publication in @CellReports. Their study reveals how targeting SETDB1 enhances NK cell immunosurveillance in monocytic AML, potentially offering new therapies for this treatment-resistant leukemia subtype.
Anna E. Beaudin retweeted
Microbiology & Immunology and the Huntsman Cancer Institute at the University of Utah are working together to hire a faculty position in the area of Microbiota and cancer. utah.peopleadmin.com/posting…
Anna E. Beaudin retweeted
Our new report in @e_JHaem on #VEXAS with non-canonical UBA1 mutations like Gly477Ala and how they may impact clinical phenotypes differently from Met41 variants by impairing E2 Ub transfer. Great work by @UofUInternalMed IM resident @Sara Zhukovsky!!!
onlinelibrary.wiley.com/doi/…
Anna E. Beaudin retweeted
Yale CCEH is holding the Rising Stars in Hematology Seminar Series! Join them on the 3rd Friday of each month at 12 pm ET! Rob Welner, PhD is leading the next seminar with his talk on "Complexity of active signaling pathways contributing to altered hematopoiesis".@YaleCCEH
Anna E. Beaudin retweeted
07 October 2024 at 16.00 CET
Erasmus Hematology Virtual Lecture.
We have:
Kellie Machlus, Boston Children’s , with
"Unraveling roles for megakaryocytes beyond platelet production through novel model systems"
Spread the news!
us06web.zoom.us/j/8272215941…
@theclotthickens